Sangamo BioSciences, Inc. Announces Presentation Of Data From ZFP Therapeutic(TM) Neurology Programs At Keystone Symposium

KEYSTONE, Colo., June 14 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO - News) today announced presentation of data from two of the Company's zinc finger DNA-binding protein (ZFP) Therapeutic(TM) neurology programs at the Keystone Symposium "Pain Mechanisms and the Development of Analgesics." The meeting is being held in Keystone, Colorado from June 11-16, 2006.

Back to news